DOCK7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.113400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.417200E-01
Normal-vs-Stage2
3.499200E-01
Normal-vs-Stage3
9.291500E-02
Normal-vs-Stage4
8.025400E-01
Stage1-vs-Stage2
4.868800E-01
Stage1-vs-Stage3
2.535200E-01
Stage1-vs-Stage4
7.603900E-02
Stage2-vs-Stage3
1.037790E-01
Stage2-vs-Stage4
1.380990E-01
Stage3-vs-Stage4
1.687650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.615800E-01
Normal-vs-AfricanAmerican
9.249200E-01
Normal-vs-Asian
4.468000E-01
Caucasian-vs-AfricanAmerican
7.858300E-02
Caucasian-vs-Asian
9.526800E-01
AfricanAmerican-vs-Asian
2.501600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.658400E-01
Normal-vs-Female
3.988000E-01
Male-vs-Female
2.280600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.261000E-01
Normal-vs-Age(41-60Yrs)
7.457600E-01
Normal-vs-Age(61-80Yrs)
2.043200E-01
Normal-vs-Age(81-100Yrs)
1.395350E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.839830E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.806000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.587000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.353200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.120200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.761400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.733020E-01
Normal-vs-Daily Drinker
1.621360E-01
Normal-vs-Weekly Drinker
2.199200E-01
Normal-vs-Occasional Drinker
7.056400E-01
Normal-vs-Social Drinker
4.395800E-01
Non Drinker-vs-Daily Drinker
6.097200E-01
Non Drinker-vs-Weekly Drinker
9.974000E-01
Non Drinker-vs-Occasional Drinker
4.429900E-02
Non Drinker-vs-Social Drinker
4.936800E-01
Daily Drinker-vs-Weekly Drinker
6.845200E-01
Daily Drinker-vs-Occasional Drinker
2.891700E-02
Daily Drinker-vs-Social Drinker
3.260400E-01
Weekly Drinker-vs-Occasional Drinker
9.349800E-02
Weekly Drinker-vs-Social Drinker
5.763000E-01
Occasional Drinker-vs-Social Drinker
3.353600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.445800E-01
Normal-vs-Grade 2
8.259200E-01
Normal-vs-Grade 3
8.132200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.537900E-02
Grade 1-vs-Grade 3
8.163700E-02
Grade 1-vs-Grade 4
9.445800E-01
Grade 2-vs-Grade 3
7.903800E-01
Grade 2-vs-Grade 4
8.259200E-01
Grade 3-vs-Grade 4
8.132200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.483400E-01
Normal-vs-NonDiabetic
2.922600E-01
Diabetic-vs-NonDiabetic
1.954190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.852200E-01
Normal-vs-NoPancreatitis
2.645000E-01
Pancreatitis-vs-NoPancreatitis
7.955600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.076600E-01
Normal-vs-N1
3.473800E-01
N0-vs-N1
5.984200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.073600E-01
Normal-vs-TP53-NonMutant
3.275600E-01
TP53-Mutant-vs-TP53-NonMutant
6.127600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
